Wendy L. Dixon - Apr 6, 2022 Form 3 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
Director
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
Stock symbol
BDTX
Transactions as of
Apr 6, 2022
Transactions value $
$0
Form type
3
Date filed
4/7/2022, 04:13 PM
Previous filing
Apr 4, 2022
Next filing
Jun 14, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney